Literature DB >> 6432088

Autoantibodies in lupus and its variants: experience in 1000 patients.

G R Hughes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432088      PMCID: PMC1442384          DOI: 10.1136/bmj.289.6441.339

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  22 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Precipitating auto-antibodies in the connective tissue diseases.

Authors:  J R ANDERSON; K G GRAY; J S BECK; W W BUCHANAN; A J McELHINNEY
Journal:  Ann Rheum Dis       Date:  1962-12       Impact factor: 19.103

3.  Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

Authors:  R L Travers; G R Hughes; G Cambridge; J R Sewell
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

4.  Extractable nuclear antigens.

Authors:  T L Moore; T D Weiss; S H Neucks; A R Baldassare; J Zuckner
Journal:  Semin Arthritis Rheum       Date:  1981-05       Impact factor: 5.532

5.  Mixed connective tissue disease: a subsequent evaluation of the original 25 patients.

Authors:  S H Nimelstein; S Brody; D McShane; H R Holman
Journal:  Medicine (Baltimore)       Date:  1980-07       Impact factor: 1.889

Review 6.  ANA-negative SLE.

Authors:  P J Maddison
Journal:  Clin Rheum Dis       Date:  1982-04

7.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Antibodies to histones in drug-induced and idiopathic lupus erythematosus.

Authors:  M J Fritzler; E M Tan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

10.  Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.

Authors:  E M Lafer; J Rauch; C Andrzejewski; D Mudd; B Furie; B Furie; R S Schwartz; B D Stollar
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  12 in total

1.  Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Authors:  Cynthia Wright; Sahar Sibani; David Trudgian; Roman Fischer; Benedikt Kessler; Joshua LaBaer; Paul Bowness
Journal:  Mol Cell Proteomics       Date:  2012-02       Impact factor: 5.911

Review 2.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 3.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

4.  Selective polyclonal increase of immunoglobulin G1 subclass: a link with Sjögren's syndrome.

Authors:  E M Hay; A J Freemont; R A Kay; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

5.  Lupus nephritis: more answers needed.

Authors:  F Wang
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

6.  Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression.

Authors:  A Kitani; M Hara; T Hirose; M Harigai; K Suzuki; M Kawakami; Y Kawaguchi; T Hidaka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

7.  Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.

Authors:  G Fellows; N Gittoes; D G Scott; J S Coppock; A Wainwright; M Goodall; B M Turner
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

8.  Thyroid disorders in systemic lupus erythematosus.

Authors:  K L Goh; F Wang
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

9.  Antibodies to extractable cellular antigens in Spanish systemic lupus erythematosus (SLE) patients.

Authors:  P E Carreira; I Mateo; G Garcia; G Garrido; J Gomez-Reino
Journal:  Clin Rheumatol       Date:  1987-03       Impact factor: 2.980

10.  Interstitial lung disease as the presentation of anti-Jo-1 positive polymyositis.

Authors:  P Nash; L Schrieber; J Webb
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.